| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.003 |
| mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.01 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
| mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.02 |
| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.13 |
0.02 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |